Mural Oncology plc
Price Action
Technical Summary
WEAKENINGMural Oncology plc is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 24), showing significant lag compared to the market leaders. Earnings growth of 89% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $2.06 | -1.21% | BELOW |
| 50 SMA | $2.08 | -1.79% | BELOW |
| 100 SMA | $2.07 | -1.33% | BELOW |
| 150 SMA | $2.23 | -8.66% | BELOW |
| 200 SMA | $2.34 | -12.65% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is MURA in an uptrend right now?
MURA has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is MURA overbought or oversold?
MURA's RSI (14) is 40. The stock is in neutral territory, neither overbought nor oversold.
Is MURA outperforming the market?
MURA has a Relative Strength (RS) Rating of 24 out of 99. MURA is currently lagging the broader market.
Where is MURA in its 52-week range?
MURA is trading at $2.04, which is 77% of its 52-week high ($2.64) and 46% above its 52-week low ($1.53).
How volatile is MURA?
MURA has a Beta of -0.40 and 52-week volatility of 47%. It's less volatile than the S&P 500 - generally more stable.